Price Chart

Profile

Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. ItĀ operates in the U.S.
URL https://www.omegatherapeutics.com
Investor Relations URL https://ir.omegatherapeutics.com/
HQ State/Province Massachusetts
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Nov. 08, 2024 (est.)
Last Earnings Release Aug. 06, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. ItĀ operates in the U.S.
URL https://www.omegatherapeutics.com
Investor Relations URL https://ir.omegatherapeutics.com/
HQ State/Province Massachusetts
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Growth
Next Earnings Release Nov. 08, 2024 (est.)
Last Earnings Release Aug. 06, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A